Cisplatin induces DNA double-strand break formation in Escherichia coli dam mutants.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  DNA Repair

• Publication date

  2005-07-12

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.DNAREP.2005.03.006PMID 15925551
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Separation of mutation avoidance and antirecombination functions in an Escherichia coli mutS mutant

  2005cited by this paper
• Viability of Escherichia coli K-12 DNA adenine methylase (dam) mutants requires increased expression of specific genes in the SOS regulon

  2004cited by this paper
• Practical Bioinformatics

  2004cited by this paper
• The DNA repair helicase UvrD is essential for replication fork reversal in replication mutants

  2004cited by this paper
• MutS inhibits RecA-mediated strand exchange with platinated DNA substrates.

  2004cited by this paper
• Spontaneous and cisplatin-induced recombination in Escherichia coli.

  2004cited by this paper
• Binding Discrimination of MutS to a Set of Lesions and Compound Lesions (Base Damage and Mismatch) Reveals Its Potential Role as a Cisplatin-damaged DNA Sensing Protein*

  2003cited by this paper
• Curing metastatic testicular cancer

  2002cited by this paper
• Survival and induction of SOS in Escherichia coli treated with cisplatin, UV-irradiation, or mitomycin C are dependent on the function of the RecBC and RecFOR pathways of homologous recombination.

  2001cited by this paper
• Mutational Analysis of the MutH Protein fromEscherichia coli *

  2001cited by this paper
• Mechanisms of resistance to cisplatin.

  2001cited by this paper
• Multiple pathways of recombination define cellular responses to cisplatin.

  2000cited by this paper
• Multiple genetic pathways for restarting DNA replication forks in Escherichia coli K-12.

  2000cited by this paper
• Role of PriA in Replication Fork Reactivation inEscherichia coli

  2000cited by this paper
• Recombination Is Essential for Viability of anEscherichia coli dam (DNA Adenine Methyltransferase) Mutant

  2000cited by this paper
• Initiation of genetic recombination and recombination-dependent replication.

  2000cited by this paper
• The importance of repairing stalled replication forks

  2000cited by this paper
• RuvAB acts at arrested replication forks.

  1998cited by this paper
• Conflicting Roles of Mismatch and Nucleotide Excision Repair in Cellular Susceptibility to Anticancer Drugs

  1998cited by this paper
• Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts.

  1997cited by this paper
• Mismatch repair in replication fidelity, genetic recombination, and cancer biology.

  1996cited by this paper
• The role of DNA mismatch repair in platinum drug resistance.

  1996cited by this paper
• Collapse and repair of replication forks in Escherichia coli

  1995cited by this paper
• DNA interstrand cross-links of trans-diamminedichloroplatinum(II) are preferentially formed between guanine and complementary cytosine residues.

  1993cited by this paper
• Expression of the Escherichia coli dam gene

  1992cited by this paper
• Initiation of methyl-directed mismatch repair.

  1992cited by this paper
• A physical genome map of Pseudomonas aeruginosa PAO.

  1989cited by this paper
• Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts.

  1988cited by this paper
• Characterization of bifunctional adducts produced in DNA by trans-diamminedichloroplatinum(II).

  1988cited by this paper
• Inviability of dam recA and dam recB cells of Escherichia coli is correlated with their inability to repair DNA double-strand breaks produced by mismatch repair

  1986cited by this paper
• Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.

  1985cited by this paper
• Mismatch repair of cis-diamminedichloroplatinum(II)-induced DNA damage.

  1985cited by this paper
• Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA.

  1985cited by this paper
• Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II).

  1983cited by this paper
• Phenotypic reversal in dam mutants of Escherichia coli K-12 by a recombinant plasmid containing the dam+ gene

  1983cited by this paper
• Biological function for 6-methyladenine residues in the DNA of Escherichia coli K12.

  1974cited by this paper
• Effect of cis-Platinum(II)Diamminodichloride on Wild Type and Deoxyribonucleic Acid Repair-Deficient Mutants of Escherichia coli

  1973cited by this paper
• Discontinuities in the DNA synthesized in an excision-defective strain of Escherichia coli following ultraviolet irradiation.

  1968cited by this paper
• TRANSDUCTION OF THE ATTACHED SEX FACTOR OF ESCHERICHIA COLI

  1962cited by this paper
• [The role of the inducible alleles and the constrtutive alleles in the synthesis of beta-galactosidase in zygotes of Escherichia coli].

  1958cited by this paper
• MUTANTS OF ESCHERICHIA COLI REQUIRING METHIONINE OR VITAMIN B12

  1950cited by this paper

• A highly cytotoxic Pd(II) saccharinate complex with tris(2-pyridylmethyl)amine acting through mitochondrial and ROS-induced DNA damage

  2025cites this paper
• Cationic first-row transition metal saccharinate complexes with tris(2-pyridylmethyl)amine: synthesis, structures and anticancer studies.

  2024cites this paper
• Synergistic Effect of SOS Response and GATC Methylome Suppression on Antibiotic Stress Survival in Escherichia coli

  2023cites this paper
• Identification of genetic interactions with priB links the PriA/PriB DNA replication restart pathway to double-strand DNA break repair in Escherichia coli

  2022cites this paper
• The ssDNA Theory of BRCAness and Genotoxic Agents

  2021cites this paper
• Exploiting the Prevalence of Homologous Recombination Deficiencies in High-Grade Serous Ovarian Cancer

  2020cites this paper
• Chemoresistant ovarian cancer enhances its migration abilities by increasing store-operated Ca2+ entry-mediated turnover of focal adhesions

  2020cites this paper
• Replication Gaps Underlie BRCA Deficiency and Therapy Response

  2020cites this paper
• Inhibition of Type IV Secretion Activity and Growth of Helicobacter pylori by Cisplatin and Other Platinum Complexes

  2020cites this paper
• Identi fi cation Of Natural Compound Derivative For Inhibition Of XLF And Overcoming Chemoresistance In Colorectal Cancer Cells

  2019cites this paper
• Identi fi cation Of Natural Compound Derivative For Inhibition Of XLF And Overcoming Chemoresistance In Colorectal Cancer Cells

  2019cites this paper
• Identification Of Natural Compound Derivative For Inhibition Of XLF And Overcoming Chemoresistance In Colorectal Cancer Cells

  2019cites this paper
• Monofunctional supramolecular Pt(II) complexes: Synthesis, single crystal structure, anticancer activity, E. coli growth retardation and DNA interaction study

  2019cites this paper
• Oxaliplatin effects on the DNA molecule studied by force spectroscopy

  2019cites this paper
• Icotinib hydrochloride enhances chemo- and radiosensitivity by inhibiting EGFR signaling and attenuating RAD51 expression and function in Hela S3 cells

  2018cites this paper
• Carboplatin as an alternative to Cisplatin in chemotherapies: New insights at single molecule level.

  2018cites this paper
• Regulation of DNA damage repair and lipid uptake by CX3CR1 in epithelial ovarian carcinoma

  2018cites this paper
• Force spectroscopy unravels the role of ionic strength on DNA-cisplatin interaction: Modulating the binding parameters.

  2017cites this paper
• Mechanisms of bacterial DNA replication restart

  2017cites this paper
• A Novel Combination Therapy of Cisplatin with a Molecular Promoter for Cancer Treatment

  2017cites this paper
• Synthesis and characterization of trans-Pt(II)(salicylaldimine)(pyridine/pyridine-4-carbinol)Cl complexes: In vivo inhibition of E. coli growth and in vitro anticancer activities

  2015cites this paper
• Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells.

  2015cites this paper
• Crosstalk between BRCA-Fanconi anemia and mismatch repair pathways prevents MSH2-dependent aberrant DNA damage responses

  2014cites this paper
• Fuse or die: how to survive the loss of Dam in Vibrio cholerae

  2014influential citation
• Role of XRCC3, XRCC1 and XPD single-nucleotide polymorphisms in survival outcomes following adjuvant chemotherapy in early stage breast cancer patients

  2014cites this paper
• The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles.

  2013cites this paper
• Identification of genes involved in low aminoglycoside-induced SOS response in Vibrio cholerae: a role for transcription stalling and Mfd helicase

  2013cites this paper
• FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.

  2013cites this paper
• Impact of cytostatic drugs on the DNA stability of higher plants

  2013cites this paper
• MutS Homologue hMSH5: Recombinational DSB Repair and Non-Synonymous Polymorphic Variants

  2013cites this paper
• MutS homologue hMSH5: role in cisplatin-induced DNA damage response

  2012cites this paper
• Bleomycin Sensitivity in Escherichia coli is Medium-Dependent

  2012cites this paper
• DNA Mismatch Repair

  2012cites this paper
• Induction and repair of DNA double-strand breaks using constant-field gel electrophoresis and apoptosis as predictive markers for sensitivity of cancer cells to cisplatin.

  2012cites this paper
• Avaliação da resistência de células-tronco derivadas de tecido adiposo humano a quimioterápicos

  2012cites this paper
• Electron transfer-based combination therapy of cisplatin with tetramethyl-p-phenylenediamine for ovarian, cervical, and lung cancers

  2012cites this paper
• Activation of DNA damage response pathways in human mesenchymal stem cells exposed to cisplatin or γ-irradiation

  2011cites this paper
• Validation and application of Drosophila melanogaster as an in vivo model for the detection of double strand breaks by neutral Comet assay.

  2011cites this paper
• Determination of hypersensitivity to genotoxic agents among Escherichia coli single gene knockout mutants.

  2010cites this paper
• FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells

  2010cites this paper
• FOXM 1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells

  2010cites this paper
• Evaluation of the genotoxicity of cisplatin, paclitaxel and 5-fluorouracil combined treatment in the Drosophila wing-spot test.

  2010cites this paper
• Synthesis, characterization, DNA binding and cleavage studies of chiral Ru(II) salen complexes.

  2009cites this paper
• Expansion of a chromosomal repeat in Escherichia coli: roles of replication, repair, and recombination functions

  2009cites this paper
• Bile-induced damage in Listeria monocytogenes

  2009cites this paper
• DNA Methylation

  2009cites this paper
• DNA mismatch repair-induced double-strand breaks.

  2008influential citation
• Activities of DNA-PK and Ku86, but not Ku70, may predict sensitivity to cisplatin in human gliomas

  2008cites this paper
• Valproic acid resensitizes cisplatin‐resistant ovarian cancer cells

  2008cites this paper
• Plasmid expression of mutS, -L and/or -H gene in Escherichia coli dam cells results in strains that display reduced mutation frequency.

  2008cites this paper
• Dam Methyltransferase Is Required for Stable Lysogeny of the Shiga Toxin (Stx2)-Encoding Bacteriophage 933W of Enterohemorrhagic Escherichia coli O157:H7

  2007cites this paper
• Molecular reaction mechanisms of combination treatments of low-dose cisplatin with radiotherapy and photodynamic therapy.

  2007cites this paper
• Electron transfer reaction mechanism of cisplatin with DNA at the molecular level.

  2007cites this paper
• Bacterial DNA repair genes and their eukaryotic homologues: 5. The role of recombination in DNA repair and genome stability.

  2007cites this paper
• In vivo inhibition of E. coli growth by a Ru(II)/Pt(II) supramolecule [(tpy)RuCl(dpp)PtCl2](PF6).

  2007cites this paper
• XthA (Exonuclease III) regulates loading of RecA onto DNA substrates in log phase Escherichia coli cells

  2007cites this paper
• The role of replication initiation control in promoting survival of replication fork damage

  2006cites this paper
• Repair of DNA Damage Induced by Bile Salts in Salmonella enterica

  2006cites this paper
• A novel dnaC mutation that suppresses priB rep mutant phenotypes in Escherichia coli K‐12

  2006cites this paper
• Differential effects of cisplatin and MNNG on dna mutants of Escherichia coli.

  2005cites this paper
• MutS inhibits RecA-mediated strand transfer with methylated DNA substrates

  2005influential citation
• Analysis of Global Gene Expression and Double-Strand-Break Formation in DNA Adenine Methyltransferase- and Mismatch Repair-Deficient Escherichia coli

  2005cites this paper
• Separation of mutation avoidance and antirecombination functions in an Escherichia coli mutS mutant

  2005influential citation
• Send Orders of Reprints at Reprints@benthamscience.net Muts Homologues Hmsh4 and Hmsh5: Genetic Variations, Functions, and Implications in Human Diseases

  year unknowncites this paper
• Identi fi cation Of Natural Compound Derivative For Inhibition Of XLF And Overcoming Chemoresistance In Colorectal Cancer Cells

  year unknowncites this paper